Literature DB >> 28002518

Oral toxicity study of certain plant extracts containing pyrrolizidine alkaloids.

Oana Cristina Şeremet1, Florica Bărbuceanu, Floriana Elvira Ionică, Denisa Marilena Margină, Claudia Maria GuŢu, Octavian Tudorel Olaru, Mihaela Ilie, Veaceslav Gonciar, Simona Negreş, Cornel ChiriŢă.   

Abstract

Pyrrolizidine alkaloids (PAs) are a class of toxic compounds which are found in plants. Poisoning caused by these toxins is associated with acute and chronic liver damage. Tussilago farfara (coltsfoot), Petasites hybridus (common butterbur), Senecio vernalis (eastern groundsel) and Symphytum officinale (comfrey) are traditional phytotherapic species, which beside the therapeutic bioactive compounds contain PAs. The aim of the paper was to assess the safety of some dry extracts obtained from these species. For the determination of acute toxicity, Organization for Economic Cooperation and Development (OECD) Guideline No. 423 was used. For the determination of repeated dose oral toxicity, Senecionis vernalis herba and Symphyti radix extracts (250 mg÷kg) were administrated, by gavage, for 28 days, and their effects on animal weight, liver and biliary functions, hepatic tissue and oxidative stress were investigated. After the acute toxicity testing, the dry extracts were placed in the GHS Category V (LD50>5000 mg÷kg, p.o.). For the subacute toxicity testing, no death or any signs of toxicity were observed. Also, no significant differences in biochemical parameters were observed between control and treated groups. The observed histopathological lesions were non-specific and were not consistent with the data reported in the literature for PAs exposure. In conclusion, the administration for 28 days, of the tested extracts, in a dose which correspond to a PAs concentration over the limits imposed in some countries, produced no hepatic and biliary toxic effects. Further studies, extended over a longer period of time, are needed in order to determine the safety of plant extracts containing PAs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28002518

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  6 in total

1.  Cytotoxic and antimicrobial potential of different leaves extracts of R. fruticosus used traditionally to treat diabetes.

Authors:  Afaf M Weli; Hanady S Al-Saadi; Rouqaya S Al-Fudhaili; Amzad Hossain; Zabida Binti Putit; Mahmood K Jasim
Journal:  Toxicol Rep       Date:  2020-01-18

Review 2.  Natural product derived phytochemicals in managing acute lung injury by multiple mechanisms.

Authors:  Yu-Qiong He; Can-Can Zhou; Lu-Yao Yu; Liang Wang; Jiu-Ling Deng; Yu-Long Tao; Feng Zhang; Wan-Sheng Chen
Journal:  Pharmacol Res       Date:  2020-09-29       Impact factor: 7.658

Review 3.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

4.  Toxicity of plant extracts containing pyrrolizidine alkaloids using alternative invertebrate models.

Authors:  Oana Cristina Seremet; Octavian Tudorel Olaru; Claudia Maria Gutu; George Mihai Nitulescu; Mihaela Ilie; Simona Negres; Cristina Elena Zbarcea; Carmen Nicoleta Purdel; Demetrios A Spandidos; Aristides M Tsatsakis; Michael D Coleman; Denisa Marilena Margina
Journal:  Mol Med Rep       Date:  2018-03-26       Impact factor: 2.952

5.  New 2-(4-(4-bromophenylsulfonyl)phenyl)-4-arylidene-oxazol-5(4H)-ones: analgesic activity and histopathological assessment.

Authors:  Florica Bărbuceanu; Elena Valentina Roşca; Theodora Venera Apostol; Oana Cristina Şeremet; Constantin Drăghici; Dragoş Paul Mihai; Simona Negreş; George Mihai Niţulescu; Ştefania Felicia Bărbuceanu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

Review 6.  Anti-inflammatory Properties of the Genus Symphytum L.: A Review.

Authors:  Elaheh Mahmoudzadeh; Hossein Nazemiyeh; Sanaz Hamedeyazdan
Journal:  Iran J Pharm Res       Date:  2022-04-05       Impact factor: 1.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.